SABLE REYNOLDS: Open Payments
NPI 1902385974 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $920
Food & beverage: $858Education: $62
| Company | Payments | Amount |
|---|---|---|
| BIOTISSUE HOLDINGS INC. | 3 | $257 |
| Oyster Point Pharma, Inc. | 7 | $238 |
| Sight Sciences, Inc. | 4 | $164 |
| Tarsus Pharmaceuticals, Inc. | 3 | $82 |
| Bausch & Lomb Americas Inc. | 2 | $40 |
| Dompe US, Inc. | 2 | $39 |
| Glaukos Corporation | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $19 |
Products named: TYRVAYA, OMNI SURGICAL SYSTEM, XDEMVY, OXERVATE, iDoseTR, Cequa, VYZULTA, Izervay.
Industry payments across LA — which companies pay providers there.
